Home Business Zydus Cadila gets final approval from USFDA to market Potassium Chloride Capsules

Zydus Cadila gets final approval from USFDA to market Potassium Chloride Capsules

87
0
SHARE
(G.N.S) Dt. 15 Ahmedabad Giving out an approval USFDA has sent final approval to Zydus Cadila to market Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg). A capsule Potassium Chloride Extended-Release Capsules USP, 8 mEq (600 mg) and 10 mEq (750 mg) It will be manufactured at the group’s formulations manufacturing facility at Ahmedabad, says a company statement. This medication is a mineral supplement

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In